PMID- 37180243 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230516 IS - 1664-302X (Print) IS - 1664-302X (Electronic) IS - 1664-302X (Linking) VI - 14 DP - 2023 TI - Streptococcus suis contributes to inguinal lymph node lesions in piglets after highly pathogenic porcine reproductive and respiratory syndrome virus infection. PG - 1159590 LID - 10.3389/fmicb.2023.1159590 [doi] LID - 1159590 AB - The swine pathogens porcine reproductive and respiratory syndrome virus (PRRSV) and Streptococcus suis have both been reported to cause damage to the immune organs. Inguinal lymph node (ILN) injury has been reported in PRRSV-infected pigs with secondary S. suis infection, but not much is known about the mechanism. In this study, secondary S. suis infection after highly pathogenic (HP)-PRRSV infection caused more severe clinical symptoms, mortality, and ILN lesions. Histopathological lesions were seen in ILNs with a marked decrease in lymphocyte numbers. Terminal deoxynucleotidyl transferase (TdT)-mediated de-oxyuridine triphosphate (dUTP)-biotin nick end-labeling (TUNEL) assays revealed that HP-PRRSV strain HuN4 alone induced ILN apoptosis, but dual-infection with S. suis strain BM0806 induced greater levels of apoptosis. Besides, we found that some HP-PRRSV-infected cells underwent apoptosis. Furthermore, anti-caspase-3 antibody staining confirmed that ILN apoptosis was mainly induced by a caspase-dependent pathway. Pyroptosis was also observed in HP-PRRSV-infected cells, and there was more pyroptosis in piglets infected with HP-PRRSV alone compared with those with secondary S. suis infection, and HP-PRRSV-infected cells underwent pyroptosis. Altogether, this is the first report to identify pyroptosis in ILNs and which signaling pathway is related to ILN apoptosis in single or dual-infected piglets. These results contribute to a better understanding of the pathogenic mechanisms during secondary S. suis infection. CI - Copyright (c) 2023 Wang, Xu, Yang, Zhang, Li, Tang, Wang, Leng, An and Cai. FAU - Wang, Shujie AU - Wang S AD - State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China. AD - Heilongjiang Provincial Key Laboratory of Veterinary Immunology, Harbin, China. FAU - Xu, Min AU - Xu M AD - Sinopharm Animal Health Corporation Ltd., Wuhan, China. FAU - Yang, Kongbin AU - Yang K AD - Neurosurgery Department, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. FAU - Zhang, Ying AU - Zhang Y AD - Shandong Binzhou Animal Science and Veterinary Medicine Academy, Binzhou, China. FAU - Li, Siqi AU - Li S AD - State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China. FAU - Tang, Yan-Dong AU - Tang YD AD - State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China. FAU - Wang, Jinliang AU - Wang J AD - Shandong Binzhou Animal Science and Veterinary Medicine Academy, Binzhou, China. FAU - Leng, Chaoliang AU - Leng C AD - Henan Key Laboratory of Insect Biology in Funiu Mountain, Henan Provincial Engineering Laboratory of Insects Bio-Reactor, China-UK-NYNU-RRes Joint Laboratory of Insect Biology, Nanyang Normal University, Nanyang, China. FAU - An, Tongqing AU - An T AD - State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China. FAU - Cai, Xuehui AU - Cai X AD - State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China. LA - eng PT - Journal Article DEP - 20230427 PL - Switzerland TA - Front Microbiol JT - Frontiers in microbiology JID - 101548977 PMC - PMC10172469 OTO - NOTNLM OT - HP-PRRSV OT - Streptococcus suis OT - apoptosis OT - inguinal lymph nodes OT - pyroptosis COIS- MX was employed by the company Sinopharm Animal Health Corporation Ltd., Wuhan, China. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2023/05/14 19:13 MHDA- 2023/05/14 19:14 PMCR- 2023/04/27 CRDT- 2023/05/14 12:03 PHST- 2023/02/06 00:00 [received] PHST- 2023/04/13 00:00 [accepted] PHST- 2023/05/14 19:14 [medline] PHST- 2023/05/14 19:13 [pubmed] PHST- 2023/05/14 12:03 [entrez] PHST- 2023/04/27 00:00 [pmc-release] AID - 10.3389/fmicb.2023.1159590 [doi] PST - epublish SO - Front Microbiol. 2023 Apr 27;14:1159590. doi: 10.3389/fmicb.2023.1159590. eCollection 2023.